Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Daily multivitamin may slow metabolic aging in midlife women

NCT ID NCT07433049

Disease control Sponsor: Institute for Human Development and Potential (IHDP), Singapore Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether taking a daily multivitamin and multimineral supplement for 12 months can improve metabolic, mental, and muscle health in women aged 40-60. Researchers will measure changes in a biomarker called MetaboAge, which reflects overall metabolic health. The trial involves 400 Asian women in Singapore and compares the supplement to a placebo.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
multivitamin and multimineral supplement
What this could lead to
If it works, this could show that a simple daily multivitamin helps midlife women maintain better metabolic health and slow age-related changes.
What could go wrong
This is a relatively small, early-stage trial focused on biomarkers, not hard outcomes like disease prevention. The benefits may be modest or not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 60 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 40-60 years old * Chinese, Malay or Indian * BMI between 23.0-35.0 kg/m2 * Proficient in English language * Willing to comply with study protocol \& provide informed consent Exclusion Criteria: * Pregnant or planning a pregnancy * Diagnosis with Diabetes, Polycystic Ovary Syndrome (PCOS), autoimmune diseases, chronic organ failure, severe heart disease, eating disorders and/or other medical conditions which in the PI's judgment which may affect study outcomes * Fasting glucose value ≥ 7.0 mmol/L * Active cancer or treatment of cancer in the last 3 years * Participating in other nutritional intervention studies * Taking oral corticosteroids, anti-psychotic and/or weight loss drugs * Having planned hospitalization in the next 12 months * Planning to have major diet changes in the next 12 months * Taking a medically prescribed supplement(s) that contains 3 or more of the ingredients of the study product * Taking a non-prescribed supplement(s) that contains 3 or more of the ingredients of the study product in the last 1 month

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Body composition are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Body composition Glucose control Mental health Musculoskeletal health

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Institute for Human Development and Potential (IHDP)

    RECRUITING

    Singapore, 117597, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.